Teleflex Incorporated will showcase the LMA® Gastro™ Airway and other key products in its Anesthesia portfolio, together with its innovative Vascular Access platform, at the Euroanesthesia Congress.
Throughout ESA 2018, Teleflex will focus on the LMA® Gastro™ Laryngeal Mask Airway and the Arrow EZ-IO® Intraosseous Vascular Access System.
Featuring an integrated endoscope channel that provides esophageal access while allowing the Anesthetist to establish an Airway during endoscopic procedures the LMA® Gastro™ Airway is our LMA® Airway Portfolio’s new family member.
The Arrow® EZ-IO® Intraosseous Vascular Access System can provide immediate interosseous access when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases. At ESA 2018, clinicians will be able to get hands on with the Arrow® EZ-IO® device.
Teleflex will also present a variety of its Arrow®, LMA® and Rüsch® Anesthesia Products, including, the LMA® Atomization range and the LMA® Laryngeal Mask Airway portfolio featuring the LMA® Protector and LMA® Supreme™ Second Generation Gastric Access Airways. A comprehensive Laryngoscope portfolio completes Teleflex’s Anesthesia portfolio.
During ESA 2018, Teleflex will sponsor a Satellite Symposium entitled “Exploring NORA and preliminary results from a 7 center Protector Study”, which will be chaired by Dr. Massimiliano Sorbello from Italy. The first session entitled “NORA – An evaluation of equipment and techniques introducing LMA® GASTRO™ Airway as a novel device in endoscopic procedures”, will also be presented by Dr. Massimiliano Sorbello from Italy and the second session “Multicenter study of the LMA® Protector™ Airway in non-paralyzed patients: Preliminary results” will be presented by Dr. Matilde Zaballos from Spain. The Satellite Symposium will be held on Sunday, June 3 from 12:30 to 13:30 in Room Red 1.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch® and Weck® – trusted brands united by a common sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management’s current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Cuff Pilot, EZ-IO, Deknatel, Hudson RCI, LMA, LMA Supreme, LMA Protector, Pilling, Rüsch and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. © 2018 Teleflex Incorporated. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180531005087/en/
Contacts
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
or
Emmet Dalton
Director Marketing Communications International
+353 87 333 3262
emmet.dalton@teleflex.com
Source: Teleflex Incorporated